TGF-beta / Smad
Los inhibidores de TGF-beta/Smad son compuestos que interfieren con la vía de señalización TGF-beta (Transforming Growth Factor-beta), la cual es mediada por proteínas Smad. Esta vía está involucrada en la regulación del crecimiento celular, la diferenciación, la apoptosis y la función de las células madre. La desregulación de la señalización TGF-beta/Smad está asociada con el cáncer, la fibrosis y otras enfermedades. Los inhibidores de esta vía son herramientas importantes para estudiar estas condiciones y desarrollar posibles terapias. En CymitQuimica, ofrecemos inhibidores de TGF-beta/Smad para apoyar su investigación en señalización celular, oncología y reparación de tejidos.
Se han encontrado 69 productos para "TGF-beta / Smad".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ponsegromab
CAS:Ponsegromab (PF 06946860), a humanized anti-GDF15 antibody, may treat cancer cachexia by blocking GDF15/GFRAL signaling.Pureza:100% (SEC-HPLC) - > 95%Forma y color:LiquidPeso molecular:146.08 kDaHydrochlorothiazide
CAS:Hydrochlorothiazide (HCTZ) 是一种口服有效的噻嗪类的利尿药，可抑制转化 TGF-β/Smad 信号通路。它通过打开钙激活钾 (KCA) 通道发挥直接的血管松弛作用。它改善心脏功能，减少纤维化并具有降压作用。Fórmula:C7H8ClN3O4S2Pureza:99.43% - 99.50%Forma y color:White SolidPeso molecular:297.74Oxymatrine
CAS:Oxymatrine (Oxysophoridine) is an alkaloid isolated from Sophora flavescens, used as the antibiotic.Fórmula:C15H24N2O2Pureza:98.72% - 99.72%Forma y color:White SolidPeso molecular:264.36Isoviolanthin
CAS:Isoviolanthin, a flavonoid from Dendrobium Officinale, inhibits migration of TGF-β1-treated HCC cells, non-toxic to normal cells, potential HCC therapy.Fórmula:C27H30O14Pureza:99.25% - 99.66%Forma y color:SolidPeso molecular:578.52Garetosmab
CAS:Garetosmab (REGN 2477), a human IgG4 monoclonal antibody, inhibits activin A for potential cancer treatment and FOP study.Pureza:> 95% - > 95%Forma y color:Transparent LiquidPeso molecular:145.52 kDaP17 Peptide
CAS:P17 Peptide, a human TGF-β1 inhibitory peptide, effectively blocks the activity of woodchuck TGF-β1.Fórmula:C95H139N27O21Forma y color:SolidPeso molecular:1995.29LSKL TFA
CAS:LSKL TFA (H-Leu-Ser-Lys-Leu-NH2 TFA) is a TGF-尾1 antagonist that inhibits TSP-1 binding to LAP and reduces renal interstitial fibrosis and liver fibrosis.Fórmula:C23H43F3N6O7Pureza:99.33%Forma y color:SolidPeso molecular:572.62Cirevetmab
CAS:Cirevetmab (ZTS-00521426), a caninized monoclonal antibody targeting Canis lupus familiaris TGFB1, is classified as an immunoglobulin G2-kappa.Forma y color:LiquidLinavonkibart
CAS:Linavonkibart (SRK181) is a humanized antibody targeting TGFβ1 that blocks the release of TGF-β1 protein by specifically binding latent TGF-β1.Pureza:97.4% (SDS-PAGE); 99.4% (SEC-HPLC) - 97.4% (SDS-PAGE); 99.4% (SEC-HPLC)Forma y color:LiquidPeso molecular:144.68 kDaDepiperazine-DM3189
CAS:Depiperazine-DM3189 inhibits the phosphorylation of SMAD 1/5/8 induced by bone morphogenetic protein 4 and can be used in biochemical experiments .Fórmula:C21H14N4Pureza:99.69%Peso molecular:322.36LY2382770
LY2382770 is a human monoclonal antibody (mAb) that specifically targets TGFB1. It is utilized in the study of diabetic nephropathy.ALK5-IN-83
ALK5-IN-83 (compound 13b) is an ALK5 inhibitor with an IC50 of 0.13 μM. It suppresses TGF-β1-induced Smad2 phosphorylation and cell motility in A549 cells.Fórmula:C20H23N7O2SForma y color:SolidPeso molecular:425.51Disitertide acetate
Disitertide acetate: a TGF-β1 and PI3K blocker, promotes apoptosis; inhibits receptor interaction.Fórmula:C70H113N17O24S2Pureza:95.77%Forma y color:White SolidPeso molecular:1640.88Fresolimumab
CAS:Fresolimumab (GC1008) is a human monoclonal antibody targeting active TGFβ1, TGFβ2, TGFβ3, studied for cancer and focal segmental glomerulosclerosis.Pureza:> 95% - > 95%Forma y color:Transparent LiquidPeso molecular:144.4 kDaLandogrozumab
CAS:Landogrozumab (LY2495655) is a humanized anti-GDF-8 monoclonal antibody that improves muscle size and may be used to study cancer and neurological disorders.Pureza:99% (SDS-PAGE); 97.5% (SEC-HPLC) - 99% (SDS-PAGE); 97.5% (SEC-HPLC)Forma y color:Transparent LiquidPeso molecular:142.86 kDaTGFβRI-IN-7
TGFβRI-IN-7 (compound 16W) is a potent inhibitor of TGFβRI. It effectively inhibits the phosphorylation of SMAD2/3 and reduces the viability of H22 cells, with IC50 values of 12 nM and 65 nM, respectively. In an H22 cell xenograft model, TGFβRI-IN-7 exhibits antitumor efficacy with a TGI of 79.6%.Fórmula:C27H32N6O2Forma y color:SolidPeso molecular:472.582Domagrozumab
CAS:Domagrozumab (PF-06252616) is a humanized monoclonal antibody targeting myostatin, used in studies of muscle wasting diseases.Pureza:95.83% (SEC-HPLC) - >95.0% (SDS-PAGE); 98% (SEC-HPLC)Forma y color:LiquidPeso molecular:143.96 kDaMyostatin inhibitory peptide 2 TFA
Myostatin Inhibitory Peptide 2 (compd 2) TFA is a potent inhibitor of muscle growth suppressant with a dissociation constant (Kd) of 35.9 nM. It is utilized in the study of muscle atrophy diseases.Forma y color:Odour SolidTGF-β1/Smad3-IN-1
CAS:TGF-β1/Smad3-IN-1 is an orally administrable dual inhibitor of TGF-β1/Smad3 with anti-fibrotic activity, idiopathic pulmonary fibrosis (IPF).Fórmula:C30H34N4O6SPureza:99.83%Peso molecular:578.68Sotatercept
CAS:Sotatercept (ACE-011) is an ActRIIA-Fc fusion protein and an inhibitor of activin signaling.Pureza:97% (SDS-PAGE); 97.8% (SEC-HPLC) - 97% (SDS-PAGE); 97.8% (SEC-HPLC)Forma y color:Transparent LiquidPeso molecular:38.94 kDa
